FTO (Fat Mass and Obesity-associated protein) inhibitors are being developed by several pharmaceutical and biotech companies. Some of the companies actively developing FTO inhibitors include:
- Storm Therapeutics
- Accent Therapeutics
- Maze Therapeutics
- Northern Biologics
- Ribometrix
- AstraZeneca
- Novartis
- Genentech
- Translate Bio
- Metabolic Solutions Development Company (MSDC)
It's worth noting that the development of FTO inhibitors is still in the early stages, and it may be several years before any of these treatments become available for clinical use.
@PlayMoney76 also noting this is two years old not sure
the accuracy
FTO (Fat Mass and Obesity-associated protein) inhibitors are...
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.45 |
Change
0.000(0.00%) |
Mkt cap ! $247.1M | |||
| Open | High | Low | Value | Volume |
| $1.45 | $1.45 | $1.35 | $254.2K | 185.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 212 | $1.40 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.45 | 5981 | 3 |
View Market Depth
| Last trade - 16.10pm 18/11/2024 (20 minute delay) ? |
| RAC (ASX) Chart |